That's the title of my blog post.....any suggestions are welcome.  Here's what I've written so far:

Diabetes is being called an epidemic, and in our increasingly sedentary western world experts are projecting that it is getting worse.  Like cancer pretty much everyone knows of someone who suffers from the disease.  According to the American Diabetes Association over 29 million people in the United States had the disease in 2012 (LINK).  And the International Diabetes Federation put the global number in 2015 at 415 million,  projected to climb to over 640 million (LINK).

Thankfully Diabetes is a treatable condition due to the discovery of Insulin by Canadian Dr. Frederick Banting and his team at the University of Toronto in 1922.  But while Insulin is a treatment, it is not a cure, and Diabetics have a number of health concerns to deal with while taking insulin to regulate the level of blood sugar.

One of the biggest concerns for Diabetics, if not the biggest, is Cardiovascular Disease (CVD), especially for older individuals.  

According to the American Heart Association at least 68% of Diabetics over the age of 65 die from some form of Heart Disease and 16% from Stroke, (LINK).  Even for those who are not seniors the risk is high, with the above linked AHA site noting that among adult diabetics the risk of CVD is two to four times higher. And that is regardless of how well diabetics control their blood sugar.  

And that is what Resverlogix is attempting to address with their lead compound, called Apabetalone or RVX-208.   

Any constructive criticism will be gratefully received.